Substantia nigra lesion suppresses the antagonistic effects of N- methyl-D-aspartate receptor antagonist (MK-801) on the autotomy in the rat

Neuroscience Letters

Volumn 255, Issue 3, 1998, Pages 167-171

  Tseng, Sheng Hong ^a   Lin, Swei Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Autotomy; N Methyl D aspartate receptor antagonist; Pain; Substantia nigra lesion

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEAFFERENTATION; DOPAMINERGIC SYSTEM; FEMALE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL GANGLION; SUBSTANTIA NIGRA;

ANIMALS; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GANGLIA, SPINAL; GANGLIONECTOMY; OXIDOPAMINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SELF MUTILATION; SUBSTANTIA NIGRA; TIME FACTORS;

EID: 0032561368     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00687-9     Document Type: Article

References (23)

1. Banos J.E., Verdu E., Buti M., Navarro X. Effects of dizocilpine on autotomy behavior after nerve section in mice. Brain Res. 636:1994;107-110.
2. Baumeister A.A., Hawkins M.F., Anticich T.G., Moore L.L., Higgins T.D. Bilateral intranigral microinjection of morphine and opioid peptides produces antinociception in rats. Brain Res. 411:1987;183-186.
3. Baumeister A.A., Anticich T.G., Hawkins M.F., Liter J.C., Thibodeaux H.F., Guillory E.C. Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat. Brain Res. 447:1988;116-121.
4. Baumeister A.A., Nagy M., Herbert G., Hawkins M.F., Vaughn A., Chatellier M.O. Further studies of the effects of intranigral morphine on behavioral responses to noxious stimuli. Brain Res. 525:1990;115-125.
5. Clarke P.B.S., Franklin K.B.J. Infusions of 6-hydroxydopamine into the nucleus accumbens abolish the analgesic effect of amphetamine but not of morphine in the formalin test. Brain Res. 580:1992;106-110.
6. Freed W.J., Perlow M.J., Karoum F., Seiger A., Olson L., Hoffer B.J., Wyatt R.J. Restoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8:1980;510-519.
7. Gobel S. An electron microscopic analysis of trans-synaptic effects of peripheral nerve injury subsequent tooth pulp extractions on neurons in lamina I and II of medullary dorsal horn. J. Neurosci. 4:1984;2281-2290.
8. Jedema H.P., Moghaddam B. Glutaminergic control of dopamine release during stress in the rat prefrontal cortex. J. Neurochem. 63:1994;785-788.
9. Lin M.T., Wu J.J., Chandra A., Tsay B.L. Activation of striatal dopamine receptors induces pain inhibition in rats. J. Neural. Transm. 51:1981;213-222.
10. Lyerly M.A., Rossitch E., Ovelmen-Levitt J., Nashold B.S. The deafferentation syndrome in the rats: effects of intraventricular apomorphine. Exp. Neurol. 100:1988;188-202.
11. Morgan M.J., Franklin K.B.J. 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res. 519:1990;144-149.
12. Nakamura K., Puntzman R., Maggio A.C., Augulis V., Conney A.H. Influence of 6-hydroxydopamine on the effect of morphine on the tail-flick latency. Psychopharmacologia. 31:1973;177-189.
13. Nasstrom J., Karlsson U., Berge O. Systemic or intracerebroventricular injection of NMDA receptor antagonists attenuates the antinociceptive activity of intrathecally administered NMDA receptor antagonists. Brain Res. 623:1993;47-55.
14. Ovelmen-Levitt, J., The neurophysiology of deafferentation syndromes. In B.S. Nashold and J. Ovelmen-Levitt (Eds.), Advances in Pain Research and Therapy, Vol. 19, Deafferentation Pain Syndrome: Pathophysiology and Treatment, Raven Press, New York, 1991, pp. 103-123.
15. Rossitch E., Ovelmen-Levitt J., Lyerly M.A., Nashold B.S. The deafferentation syndrome in the rat: effects of intraventricular neurotensin and cholecystokinin. Exp. Neurol. 98:1987;264-275.
16. Schmidt C.J., Fadayel G.M. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. J. Pharmacol. Exp. Ther. 277:1996;1541-1549.
17. Seltzer Z., Cohn S., Ginzburg R., Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain. 45:1991;69-75.
18. Sugimoto T., Takemura M., Sakai A., Ishimaru M. Rapid transneural destruction following peripheral nerve transection in the medullary dorsal horn enhanced by strychnine, picrotoxin and bicuculine. Pain. 30:1987;385-393.
19. Sugimoto T., Bennett G.J., Kajander K.C. Strychnine-enhanced transsynaptic degeneration of dorsal horn neurons in rats with an experimental painful neuropathy. Neurosci. Lett. 98:1989;139-143.
20. Tseng S.H. Suppression of autotomy by N-methyl-D-aspartate receptor antagonist (MK-801) in the rat. Neurosci. Lett. 240:1998;17-20.
21. Wall P.D., Devor M., Inbal R., Scadding J.W., Schonfeld D., Seltzer A., Tomkiewicz M.M. Autotomy following peripheral nerve lesions: experimental anesthesia dolorosa. Pain. 7:1979;103-113.
22. Wang J., Lonart G., Johnson K.M. Glutamate receptor activation induces carrier mediated release of endogenous GABA from rat striatal slices. J. Neural. Transm. 103:1996;31-43.
23. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.